G. Sussman, “Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study”, J of Skin, vol. 1, no. 3.1, p. s127, Oct. 2017.